Advertisement.

IPCIF Projected Dividend Yield

Intellipharmaceutics International Inc ( OTCBB : IPCIF )

Intellipharmaceutics International is a pharmaceutical company engaging in the research, development and manufacture of generic controlled-release and targeted-release oral solid dosage drugs. Co.'s products and product candidates include: Focalin XR®, which is indicated for the treatment of attention deficit hyperactivity disorder; Keppra XR®, which is indicated for use in the treatment of partial onset seizures for epilepsy; Effexor XR®, which is indicated for the treatment of depression; Protonix®, which is indicated for the treatment of conditions associated with gastroesophageal reflux disease; and Glucophage® XR, which is indicated for use in the management of type two diabetes.

20 YEAR PERFORMANCE RESULTS

IPCIF Dividend History Detail
IPCIF Dividend News
IPCIF Competitors News

# of Shares: 0

Closing Price: 0.00

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000